The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's JNJ.N therapy for treating a type of multiple myeloma, giving another treatment option to patients with the incurable blood cancer, the regulator said on Tuesday.
https://www.nasdaq.com/articles/johnson-johnsons-blood-cancer-therapy-gets-u.s.-fda-approval
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.